Pharmaceutical Business review

Par Pharmaceutical signs distribution agreement with AstraZeneca

Par began shipping 0.25mg/2ml and 0.5mg/2ml to the trade. Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to eight years of age.

Exit mobile version